ID24175A - Turunan-turunan imidazol yang mempunyai aktivitas penghambatan untuk farnesil transferase dan proses pembuatannya - Google Patents

Turunan-turunan imidazol yang mempunyai aktivitas penghambatan untuk farnesil transferase dan proses pembuatannya

Info

Publication number
ID24175A
ID24175A IDW20000933A ID20000933A ID24175A ID 24175 A ID24175 A ID 24175A ID W20000933 A IDW20000933 A ID W20000933A ID 20000933 A ID20000933 A ID 20000933A ID 24175 A ID24175 A ID 24175A
Authority
ID
Indonesia
Prior art keywords
drivings
imidazol
making
living activity
farnesil
Prior art date
Application number
IDW20000933A
Other languages
English (en)
Indonesian (id)
Inventor
Hyun Il Lee
Jong Sung Koh
Won Hee Jung
You Seung Shin
Jin Ho Lee
Hyun Ho Chung
Johg Hyun Kim
Seong Gu Ro
Tae Saeng Choi
Shin Wu Jeong
Tae Hwan Kwak
In Ae Ahn
Hyun Sung Kim
Sun Hwa Lee
Kwi Hwa Kim
Jung Kwon Yoo
Original Assignee
Lg Chemical Ltd
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Priority claimed from KR1019980011359A external-priority patent/KR19990066679A/ko
Priority claimed from KR1019980023698A external-priority patent/KR20000002788A/ko
Priority claimed from KR1019980046457A external-priority patent/KR20000015758A/ko
Application filed by Lg Chemical Ltd filed Critical Lg Chemical Ltd
Publication of ID24175A publication Critical patent/ID24175A/id

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D401/00—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom
    • C07D401/14—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom containing three or more hetero rings
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P13/00—Drugs for disorders of the urinary system
    • A61P13/12—Drugs for disorders of the urinary system of the kidneys
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P35/00—Antineoplastic agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00—Drugs for disorders of the cardiovascular system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00—Drugs for disorders of the cardiovascular system
    • A61P9/10—Drugs for disorders of the cardiovascular system for treating ischaemic or atherosclerotic diseases, e.g. antianginal drugs, coronary vasodilators, drugs for myocardial infarction, retinopathy, cerebrovascula insufficiency, renal arteriosclerosis
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D403/00—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, not provided for by group C07D401/00
    • C07D403/02—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, not provided for by group C07D401/00 containing two hetero rings
    • C07D403/06—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, not provided for by group C07D401/00 containing two hetero rings linked by a carbon chain containing only aliphatic carbon atoms
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D405/00—Heterocyclic compounds containing both one or more hetero rings having oxygen atoms as the only ring hetero atoms, and one or more rings having nitrogen as the only ring hetero atom
    • C07D405/14—Heterocyclic compounds containing both one or more hetero rings having oxygen atoms as the only ring hetero atoms, and one or more rings having nitrogen as the only ring hetero atom containing three or more hetero rings
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D413/00—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and oxygen atoms as the only ring hetero atoms
    • C07D413/02—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and oxygen atoms as the only ring hetero atoms containing two hetero rings
    • C07D413/06—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and oxygen atoms as the only ring hetero atoms containing two hetero rings linked by a carbon chain containing only aliphatic carbon atoms
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D417/00—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and sulfur atoms as the only ring hetero atoms, not provided for by group C07D415/00
    • C07D417/02—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and sulfur atoms as the only ring hetero atoms, not provided for by group C07D415/00 containing two hetero rings
    • C07D417/06—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and sulfur atoms as the only ring hetero atoms, not provided for by group C07D415/00 containing two hetero rings linked by a carbon chain containing only aliphatic carbon atoms
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D417/00—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and sulfur atoms as the only ring hetero atoms, not provided for by group C07D415/00
    • C07D417/14—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and sulfur atoms as the only ring hetero atoms, not provided for by group C07D415/00 containing three or more hetero rings

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Health & Medical Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • General Health & Medical Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Engineering & Computer Science (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Urology & Nephrology (AREA)
  • Heart & Thoracic Surgery (AREA)
  • Cardiology (AREA)
  • Vascular Medicine (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Plural Heterocyclic Compounds (AREA)
  • Pyrrole Compounds (AREA)
  • Cephalosporin Compounds (AREA)
IDW20000933A 1997-11-28 1998-11-25 Turunan-turunan imidazol yang mempunyai aktivitas penghambatan untuk farnesil transferase dan proses pembuatannya ID24175A (id)

Applications Claiming Priority (6)

Application Number Priority Date Filing Date Title
KR19970063858 1997-11-28
KR1019980011359A KR19990066679A (ko) 1997-11-28 1998-03-31 피롤구조를 갖는 파네실 전이효소 억제제 및 그의 제조방법
KR1019980023698A KR20000002788A (ko) 1998-06-23 1998-06-23 피라졸 구조를 갖는 파네실 전이효소 억제제 및그의 제조방법
KR1019980024423A KR19990062439A (ko) 1997-11-28 1998-06-26 피롤구조를 갖는 파네실 전이효소 억제제 및 그의 제조방법
KR19980031512 1998-08-03
KR1019980046457A KR20000015758A (ko) 1998-08-03 1998-10-30 피롤 구조를 갖는 파네실 전이효소 억제제 및 그의 제조방법

Publications (1)

Publication Number Publication Date
ID24175A true ID24175A (id) 2000-07-13

Family

ID=27555104

Family Applications (1)

Application Number Title Priority Date Filing Date
IDW20000933A ID24175A (id) 1997-11-28 1998-11-25 Turunan-turunan imidazol yang mempunyai aktivitas penghambatan untuk farnesil transferase dan proses pembuatannya

Country Status (18)

Country Link
US (3) US6268363B1 (fr)
EP (1) EP1045846B1 (fr)
JP (2) JP3548118B2 (fr)
CN (1) CN1188407C (fr)
AR (1) AR017700A1 (fr)
AT (1) ATE239014T1 (fr)
AU (1) AU731272B2 (fr)
BR (1) BR9815423A (fr)
CA (1) CA2310629A1 (fr)
DE (1) DE69814167T2 (fr)
ES (1) ES2193590T3 (fr)
HU (1) HUP0004238A3 (fr)
ID (1) ID24175A (fr)
IL (1) IL135473A0 (fr)
NZ (1) NZ504013A (fr)
PL (1) PL340729A1 (fr)
RU (1) RU2179975C1 (fr)
WO (1) WO1999028315A1 (fr)

Families Citing this family (48)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CN1158277C (zh) * 1998-02-02 2004-07-21 Lg化学株式会社 具有哌啶结构的法尼转移酶抑制剂及其制备方法
KR100395300B1 (ko) * 1999-08-11 2003-08-27 주식회사 엘지생명과학 피롤구조를 갖는 파네실 전이효소 억제제 및 그의 제조방법
WO2000064891A1 (fr) * 1999-04-13 2000-11-02 Lg Chem Investment Ltd. Inhibiteurs de la farnesyl-transferase ayant une structure pyrrole et leur preparation
FR2796943A1 (fr) * 1999-07-30 2001-02-02 Aventis Pharma Sa Derives de benzoxazinnes, leur procede de preparation et leur utilisation en therapeutique
KR20010063274A (ko) * 1999-12-22 2001-07-09 성재갑 〔1-｛〔1-（1,3-벤조디옥솔-5-일메틸-1ｈ-이미다졸-5-일〕메틸｝-4-(1-나프틸)-1ｈ-피롤-3-일〕（4-메틸-1-피페라지닐）메타논의 약학적 조성물
KR100412334B1 (ko) * 2000-02-22 2003-12-31 주식회사 엘지생명과학 4-치환된-1ｈ-피롤-3-카복실산 에스테르의 새로운 제조방법
AU2001244596A1 (en) * 2000-03-30 2001-10-15 Rei Asakai Indolylpyrrole derivatives and cell death inhibitors
US7304061B2 (en) * 2002-04-26 2007-12-04 Vertex Pharmaceuticals Incorporated Heterocyclic inhibitors of ERK2 and uses thereof
US7132100B2 (en) 2002-06-14 2006-11-07 Medimmune, Inc. Stabilized liquid anti-RSV antibody formulations
US7425618B2 (en) 2002-06-14 2008-09-16 Medimmune, Inc. Stabilized anti-respiratory syncytial virus (RSV) antibody formulations
RU2462463C2 (ru) * 2002-08-23 2012-09-27 Слоан-Кеттеринг Инститьют Фор Кэнсер Рисерч Синтез эпотилонов, их промежуточных продуктов, аналогов и их применения
CA2497628A1 (fr) * 2002-09-05 2004-03-18 Medimmune, Inc. Methodes de prevention ou de traitement de malignites cellulaires par administration d'antagonistes de cd2
US8034831B2 (en) 2002-11-06 2011-10-11 Celgene Corporation Methods for the treatment and management of myeloproliferative diseases using 4-(amino)-2-(2,6-Dioxo(3-piperidyl)-isoindoline-1,3-dione in combination with other therapies
US7563810B2 (en) 2002-11-06 2009-07-21 Celgene Corporation Methods of using 3-(4-amino-1-oxo-1,3-dihydroisoindol-2-yl)-piperidine-2,6-dione for the treatment and management of myeloproliferative diseases
CA2511321A1 (fr) * 2002-12-23 2004-07-08 Aventis Pharma Deutschland Gmbh Derives de pyrazole utilises en tant qu'inhibiteurs du facteur xa
EP2316487B1 (fr) 2003-04-11 2014-06-11 MedImmune, LLC Anticorps IL-9 recombinants et leurs utilisations
WO2005042743A2 (fr) 2003-08-18 2005-05-12 Medimmune, Inc. Humanisation d'anticorps
US7214825B2 (en) * 2003-10-17 2007-05-08 Honeywell International Inc. O-(3-chloropropenyl) hydroxylamine free base
US7880017B2 (en) 2003-11-11 2011-02-01 Allergan, Inc. Process for the synthesis of imidazoles
US7183305B2 (en) 2003-11-11 2007-02-27 Allergan, Inc. Process for the synthesis of imidazoles
EA200602288A1 (ru) * 2004-05-29 2007-10-26 7ТиЭм ФАРМА А/С Замещённые тиазолуксусные кислоты в качестве лигандов crth2
US20060121042A1 (en) 2004-10-27 2006-06-08 Medimmune, Inc. Modulation of antibody specificity by tailoring the affinity to cognate antigens
AU2006227377B2 (en) 2005-03-18 2013-01-31 Medimmune, Llc Framework-shuffling of antibodies
WO2007002543A2 (fr) 2005-06-23 2007-01-04 Medimmune, Inc. Formulations d'anticorps possedant des profils d'agregation et de fragmentation optimises
EP2051977A2 (fr) * 2006-07-20 2009-04-29 Amgen Inc. HÉTÉROCYCLES AROMATIQUES D'AZOLE SUBSTITUÉS, UTILISÉS EN TANT QU'INHIBITEURS DE LLbeta-HSD-1
NZ575163A (en) 2006-08-28 2011-12-22 Jolla Inst Allergy Immunolog Antagonistic human light-specific human monoclonal antibodies
MX2009010389A (es) 2007-03-30 2010-01-20 Medimmune Llc Formulacion de anticuerpos.
PE20090717A1 (es) 2007-05-18 2009-07-18 Smithkline Beecham Corp Derivados de quinolina como inhibidores de la pi3 quinasa
EP2215246B1 (fr) 2007-10-31 2015-01-07 MedImmune, LLC Structures protéiques
EP2095819A1 (fr) * 2008-02-28 2009-09-02 Maastricht University Dérivés de N-benzyle imidazole et leur utilisation comme inhibiteurs de l'aldosterone synthase
EP2668210B1 (fr) 2011-01-26 2020-06-17 Celldex Therapeutics, Inc. Anticorps anti-kit et leurs utilisations
SG11201500489YA (en) 2012-07-25 2015-02-27 Kolltan Pharmaceuticals Inc Anti-kit antibodies and uses thereof
AU2013329311A1 (en) 2012-10-09 2015-04-30 Igenica Biotherapeutics, Inc. Anti-C16orf54 antibodies and methods of use thereof
ES2891755T3 (es) 2013-06-06 2022-01-31 Pf Medicament Anticuerpos anti-C10orf54 y utilizaciones de los mismos
KR102553717B1 (ko) 2013-08-26 2023-07-11 바이오엔테크 리서치 앤드 디벨롭먼트 인코포레이티드 시알릴-루이스 ａ에 대한 사람 항체 코드화 핵산
GB201403775D0 (en) 2014-03-04 2014-04-16 Kymab Ltd Antibodies, uses & methods
JP6626461B2 (ja) 2014-06-04 2019-12-25 バイオエヌテック リサーチ アンド デベロップメント， インコーポレイテッド ガングリオシドｇｄ２に対するヒトモノクローナル抗体
WO2016094837A2 (fr) 2014-12-11 2016-06-16 Igenica Biotherapeutics, Inc. Anticorps anti-c10orf54 et leurs utilisations
BR112017015880A2 (pt) 2015-03-03 2018-07-31 Kymab Ltd anticorpos, usos e métodos
KR20180100122A (ko) 2015-12-02 2018-09-07 주식회사 에스티사이언스 당화된 btla(b- 및 t-림프구 약화인자)에 특이적인 항체
WO2017096051A1 (fr) 2015-12-02 2017-06-08 Stcube & Co., Inc. Anticorps et molécules se liant de manière immunospécifique à btn1a1 et leurs utilisations thérapeutiques
BR112019006448A2 (pt) 2016-09-29 2019-06-25 Bayer Cropscience Ag novos derivados de 5-imidazol substituídos
EP3534947A1 (fr) 2016-11-03 2019-09-11 Kymab Limited Anticorps, combinaisons comprenant des anticorps, biomarqueurs, utilisations et procédés
AU2018277838A1 (en) 2017-05-31 2019-12-19 Stcube & Co., Inc. Antibodies and molecules that immunospecifically bind to BTN1A1 and the therapeutic uses thereof
AU2018277545A1 (en) 2017-05-31 2019-12-19 Stcube & Co., Inc. Methods of treating cancer using antibodies and molecules that immunospecifically bind to BTN1A1
JP2020522562A (ja) 2017-06-06 2020-07-30 ストキューブ アンド シーオー．， インコーポレイテッド Ｂｔｎ１ａ１又はｂｔｎ１ａ１リガンドに結合する抗体及び分子を用いて癌を治療する方法
EP3694889A1 (fr) 2017-10-13 2020-08-19 Boehringer Ingelheim International GmbH Anticorps humains dirigés contre l'antigène thomsen-nouveau (tn)
CA3106418A1 (fr) 2018-07-20 2020-01-23 Pierre Fabre Medicament Recepteur pour vista

Family Cites Families (9)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
EP0300688A1 (fr) * 1987-07-21 1989-01-25 FISONS plc Dérivés de pyrrole, procédé de préparation et compositions pharmaceutiques les contenant
US5681795A (en) * 1994-03-02 1997-10-28 Zeneca Limited 3-benzoyl pyrrole and pyrazole herbicides
US5756528A (en) * 1995-06-06 1998-05-26 Merck & Co., Inc. Inhibitors of farnesyl-protein transferase
JP2000510101A (ja) 1996-03-29 2000-08-08 セラコス・インコーポレーテツド 白血球のフォトフェレーシス処置
WO1997036891A1 (fr) 1996-04-03 1997-10-09 Merk & Co., Inc. Inhibiteurs de la farnesyl-proteine transferase
JP2000507590A (ja) 1996-04-03 2000-06-20 メルク エンド カンパニー インコーポレーテッド ファルネシル―タンパク質トランスフェラーゼ阻害剤
JP2000507956A (ja) * 1996-04-03 2000-06-27 メルク エンド カンパニー インコーポレーテッド ファルネシル−タンパク質トランスフェラーゼ阻害剤
JP2001509131A (ja) 1996-04-03 2001-07-10 メルク エンド カンパニー インコーポレーテッド ファルネシルプロテイントランスフェラーゼの阻害剤
JP2000507955A (ja) 1996-04-03 2000-06-27 メルク エンド カンパニー インコーポレーテッド ファルネシル―タンパク質転移酵素の阻害剤

Also Published As

Publication number Publication date
US6268363B1 (en) 2001-07-31
AR017700A1 (es) 2001-09-12
CN1279680A (zh) 2001-01-10
CA2310629A1 (fr) 1999-06-10
ATE239014T1 (de) 2003-05-15
AU731272B2 (en) 2001-03-29
AU1508399A (en) 1999-06-16
BR9815423A (pt) 2000-10-17
HUP0004238A3 (en) 2001-07-30
CN1188407C (zh) 2005-02-09
NZ504013A (en) 2002-02-01
PL340729A1 (en) 2001-02-26
JP3548118B2 (ja) 2004-07-28
HUP0004238A2 (hu) 2001-05-28
DE69814167T2 (de) 2004-02-26
JP2002161092A (ja) 2002-06-04
EP1045846A1 (fr) 2000-10-25
EP1045846B1 (fr) 2003-05-02
IL135473A0 (en) 2001-05-20
US20020137769A1 (en) 2002-09-26
RU2000116633A (ru) 2004-02-20
ES2193590T3 (es) 2003-11-01
DE69814167D1 (de) 2003-06-05
US6472526B1 (en) 2002-10-29
RU2179975C1 (ru) 2002-02-27
WO1999028315A1 (fr) 1999-06-10
JP2001524550A (ja) 2001-12-04
US6518429B2 (en) 2003-02-11

Similar Documents

Publication Publication Date Title
ID24175A (id) Turunan-turunan imidazol yang mempunyai aktivitas penghambatan untuk farnesil transferase dan proses pembuatannya
ID19290A (id) Turunan-turunan propiofenon dan proses pembuatannya
ID22821A (id) Turunan sulfonamida, proses pembuatannya dan penggunaannya sebagai obat
ID27408A (id) Benda penyerap dan proses pembuatannya
ID26172A (id) Proses pembuatan surfaktan-surfaktan alkilbenzenasulfonat dan produk-produknya
ID23985A (id) Baterai dan metode pembuatannya
ID27859A (id) Tampon dan metoda pembuatannya
ID24929A (id) Turunan 2-aril-8-oksodihidropurin, proses pembuatannya, komposisi farmasinya yang mengandungnya, dan senyawa antaranya
IL132704A0 (en) Methods and compositions for the selective modification of nucleic acids
ID25469A (id) Komposisi sefalosporin amorf yang stabil secara kristalografi dan proses pembuatannya
IL135338A0 (en) Methods and compositions for the selective modification of nucleic acids
ID28057A (id) Obat dalam bentuk pil lunak dan proses pembuatannya
ID22782A (id) Perenggang baterai dan metoda pembuatannya
ID27126A (id) Proses pembuatan garam-garam asam karboksilat dan katalis-katalis yang berguna dalam proses tersebut
ID22641A (id) Proses pembuatan e-kaprolaktam
DE69602217D1 (de) Elektrisch gesteuertes Expansionsventil und Verfahren zu dessen Herstellung
AU1203399A (en) Catalytic structure and method of making the same
ID24070A (id) Katalis yang mengandung hologen dan proses pembuatannya
ID24600A (id) Proses pembuatan poliol-poliol polieter dan poliol yang dibuat bersamaan
ID24326A (id) Metoda pembuatan penutup lantai anti-gelincir
ID20624A (id) Proses pembuatan 2'-flouro-5-metil-betha-l-rabinofuranosiluridin
ID23304A (id) Turunan-turunan diaza-spiro [3,5] nonana, proses pembuatan dan penggunaannya
ID24173A (id) 1,2,3,4,5,6 heksahidro-2-6-metano-3-benzazosin-10-ol, proses pembuatan dan penggunannya untuk obat-obatan
ID18860A (id) Katalis hidrocracking distilat dan proses pembuatannya
ID29312A (id) Panel sisipan moduler dan metode untuk konstruksi rumah